Garg Pushkal
Insider CIK 1829252 · ALNY EVP Chief R&D · SQZ Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 654 | $322.33 | $210.8K | 20,443 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 740 | $323.55 | $239.4K | 19,703 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 510 | $324.59 | $165.5K | 19,193 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-05 | 2026-03-06 | 500 | $326.08 | $163.0K | 18,693 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 215 | $320.81 | $69.0K | 22,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 289 | $321.82 | $93.0K | 22,694 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 350 | $323.01 | $113.1K | 22,344 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 767 | $323.84 | $248.4K | 21,577 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 272 | $324.88 | $88.4K | 21,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 208 | $325.67 | $67.7K | 21,097 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 102 | $320.01 | $32.6K | 23,198 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 106 | $319.03 | $33.8K | 23,300 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 463 | $321.50 | $148.9K | 23,406 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 640 | $320.48 | $205.1K | 23,869 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 317 | $319.06 | $101.1K | 24,509 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-03 | 2026-03-04 | 355 | $316.74 | $112.4K | 24,826 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 10,480 | — | $0 | 10,480 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 277 | $325.63 | $90.2K | 26,474 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 50 | $323.62 | $16.2K | 26,848 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 42 | $332.64 | $14.0K | 25,181 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 101 | $331.93 | $33.5K | 25,223 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 87 | $330.85 | $28.8K | 25,324 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 182 | $329.71 | $60.0K | 25,411 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 107 | $328.71 | $35.2K | 25,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 353 | $327.67 | $115.7K | 25,700 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 421 | $326.81 | $137.6K | 26,053 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-03-02 | 2026-03-04 | 4,769 | — | $0 | 26,898 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 97 | $324.65 | $31.5K | 26,751 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-02-27 | 2026-03-02 | 1,908 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-27 | 2026-03-02 | 140 | $334.39 | $46.8K | 22,129 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-27 | 2026-03-02 | 942 | $332.48 | $313.2K | 22,269 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-27 | 2026-03-02 | 1,159 | $331.49 | $384.2K | 23,211 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-27 | 2026-03-02 | 2,259 | $330.73 | $747.1K | 24,370 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-27 | 2026-03-02 | 127 | $328.92 | $41.8K | 26,629 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-02-27 | 2026-03-02 | 1,908 | — | $0 | 26,756 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-13 | 2026-02-17 | 2,242 | $310.08 | $695.2K | 24,848 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-12 | 2026-02-17 | 4,579 | — | $0 | 27,090 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 47 | $363.55 | $17.1K | 23,222 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $367.40 | $15.1K | 22,712 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 92 | $368.62 | $33.9K | 22,620 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 40 | $369.48 | $14.8K | 22,580 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 18 | $370.87 | $6.7K | 22,562 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 3 | $372.46 | $1.1K | 22,559 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 14 | $374.44 | $5.2K | 22,545 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 19 | $375.65 | $7.1K | 22,526 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 199 | $364.83 | $72.6K | 23,023 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 220 | $365.56 | $80.4K | 22,803 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 98 | $361.45 | $35.4K | 23,342 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 73 | $362.38 | $26.5K | 23,269 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 50 | $366.41 | $18.3K | 22,753 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 15 | $377.82 | $5.7K | 22,511 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 39 | $353.95 | $13.8K | 23,982 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 42 | $355.16 | $14.9K | 23,940 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 41 | $356.09 | $14.6K | 23,899 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 96 | $357.17 | $34.3K | 23,803 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 123 | $358.18 | $44.1K | 23,680 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 85 | $359.14 | $30.5K | 23,595 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 155 | $360.22 | $55.8K | 23,440 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-01-11 | 2026-01-14 | 3,800 | — | $0 | 24,021 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-03 | 2025-10-03 | 215 | $454.37 | $97.7K | 20,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-03 | 2025-10-03 | 417 | $453.51 | $189.1K | 20,436 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-03 | 2025-10-03 | 898 | $451.76 | $405.7K | 20,853 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-03 | 2025-10-03 | 810 | $450.63 | $365.0K | 21,751 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-03 | 2025-10-03 | 682 | $449.99 | $306.9K | 22,561 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 147 | $457.43 | $67.2K | 23,246 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 73 | $455.82 | $33.3K | 23,393 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 244 | $454.84 | $111.0K | 23,466 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 329 | $453.77 | $149.3K | 23,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 668 | $452.69 | $302.4K | 24,039 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 332 | $451.86 | $150.0K | 24,707 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 541 | $450.81 | $243.9K | 25,039 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 249 | $449.79 | $112.0K | 25,580 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 180 | $448.77 | $80.8K | 25,829 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 56 | $447.92 | $25.1K | 26,009 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 115 | $446.53 | $51.4K | 26,065 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 3 | $457.64 | $1.4K | 23,243 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 2,851 | — | $0 | 26,180 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 3,108 | — | $0 | 23,329 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 276 | $455.41 | $125.7K | 21,400 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 45 | $461.74 | $20.8K | 20,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 338 | $457.26 | $154.6K | 21,062 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 231 | $458.27 | $105.9K | 20,831 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 260 | $459.59 | $119.5K | 20,571 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-19 | 2025-08-19 | 305 | $461.01 | $140.6K | 20,266 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 12 | $455.82 | $5.5K | 21,676 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 241 | $454.84 | $109.6K | 21,688 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 543 | $454.04 | $246.5K | 21,929 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 329 | $452.96 | $149.0K | 22,472 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $450.92 | $17.6K | 22,904 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 90 | $449.92 | $40.5K | 22,943 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 39 | $447.98 | $17.5K | 23,033 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 103 | $451.99 | $46.6K | 22,801 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-08-15 | 2025-08-19 | 2,851 | — | $0 | 23,072 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-03-24 | 2025-03-25 | 5,445 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-24 | 2025-03-25 | 5,445 | $300.00 | $1.63M | 20,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-03-24 | 2025-03-25 | 5,445 | $42.22 | $229.9K | 25,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-21 | 2025-03-25 | 4,321 | $285.00 | $1.23M | 20,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 120 | $242.70 | $29.1K | 24,542 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 198 | $241.60 | $47.8K | 24,662 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 343 | $240.92 | $82.6K | 24,860 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-04 | 2025-03-05 | 147 | $239.25 | $35.2K | 25,203 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-03-03 | 2025-03-05 | 7,819 | — | $0 | 7,819 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 116 | $245.26 | $28.5K | 26,377 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 158 | $244.41 | $38.6K | 26,493 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 235 | $243.36 | $57.2K | 26,651 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 213 | $242.37 | $51.6K | 26,886 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-03-03 | 2025-03-05 | 14,137 | — | $0 | 27,099 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 48 | $246.18 | $11.8K | 26,329 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 5 | $247.35 | $1.2K | 26,324 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 273 | $244.43 | $66.7K | 25,467 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 583 | $243.13 | $141.7K | 25,740 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 1 | $248.36 | $248 | 26,323 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 117 | $245.53 | $28.7K | 25,350 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 91 | $240.32 | $21.9K | 13,674 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 149 | $241.51 | $36.0K | 13,525 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 142 | $243.23 | $34.5K | 13,031 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 69 | $244.11 | $16.8K | 12,962 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 41 | $239.18 | $9.8K | 13,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 40 | $238.33 | $9.5K | 13,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 51 | $236.51 | $12.1K | 13,846 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 352 | $242.44 | $85.3K | 13,173 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,908 | — | $0 | 1,908 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-02-27 | 2025-03-03 | 1,908 | — | $0 | 13,897 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 306 | $250.73 | $76.7K | 12,369 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 862 | $250.11 | $215.6K | 12,675 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 80 | $259.10 | $20.7K | 11,989 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 107 | $257.99 | $27.6K | 12,069 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 83 | $256.05 | $21.3K | 12,176 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-18 | 2025-02-18 | 110 | $251.60 | $27.7K | 12,259 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 32 | $264.87 | $8.5K | 13,537 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 386 | $253.37 | $97.8K | 14,363 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 258 | $254.35 | $65.6K | 14,105 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 110 | $255.56 | $28.1K | 13,995 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 126 | $256.29 | $32.3K | 13,869 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 60 | $257.51 | $15.5K | 13,809 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 77 | $258.07 | $19.9K | 13,732 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 27 | $259.72 | $7.0K | 13,705 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 49 | $260.57 | $12.8K | 13,656 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 60 | $261.45 | $15.7K | 13,596 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 27 | $263.33 | $7.1K | 13,569 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 349 | $252.50 | $88.1K | 14,749 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-02-13 | 2025-02-18 | 3,109 | — | $0 | 15,098 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-01-27 | 2025-01-29 | 23,876 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-01-27 | 2025-01-29 | 25,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-01-27 | 2025-01-29 | 23,876 | $88.95 | $2.12M | 39,581 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-01-27 | 2025-01-29 | 52,592 | $285.00 | $14.99M | 11,989 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-01-27 | 2025-01-29 | 25,000 | $88.95 | $2.22M | 64,581 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 100 | $252.94 | $25.3K | 15,846 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 778 | $251.68 | $195.8K | 15,946 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 186 | $248.99 | $46.3K | 17,150 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 121 | $247.48 | $29.9K | 17,336 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 1 | $255.80 | $256 | 15,705 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 140 | $254.37 | $35.6K | 15,706 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-12-12 | 2024-12-13 | 426 | $250.08 | $106.5K | 16,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 97 | $252.27 | $24.5K | 17,457 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 945 | $251.42 | $237.6K | 17,554 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 364 | $250.68 | $91.2K | 18,499 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 246 | $249.60 | $61.4K | 18,863 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 30 | $247.77 | $7.4K | 19,109 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-11-25 | 2024-11-27 | 3,434 | — | $0 | 19,139 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-10-08 | 2024-10-10 | 96 | — | $0 | 15,705 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 45 | $226.82 | $10.2K | 17,548 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 242 | $234.66 | $56.8K | 15,828 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 78 | $221.71 | $17.3K | 17,634 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 17 | $224.17 | $3.8K | 17,617 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 24 | $225.55 | $5.4K | 17,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 219 | $235.19 | $51.5K | 15,609 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 169 | $228.30 | $38.6K | 17,379 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 348 | $229.06 | $79.7K | 17,031 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 398 | $229.93 | $91.5K | 16,633 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 129 | $231.59 | $29.9K | 16,504 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 283 | $232.54 | $65.8K | 16,221 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 151 | $233.53 | $35.3K | 16,070 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-06-24 | 2024-06-26 | 4,295 | — | $0 | 17,712 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 9,279 | — | $0 | 9,279 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-03-01 | 2024-03-05 | 4,751 | — | $0 | 13,417 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 1 | $158.09 | $158 | 8,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 247 | $154.54 | $38.2K | 8,993 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 194 | $155.45 | $30.2K | 8,799 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 115 | $156.38 | $18.0K | 8,684 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 17 | $157.30 | $2.7K | 8,667 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-27 | 2024-02-29 | 1,908 | — | $0 | 3,816 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-27 | 2024-02-29 | 1,908 | — | $0 | 9,240 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 480 | $147.50 | $70.8K | 8,160 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 672 | $148.24 | $99.6K | 7,488 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 156 | $149.03 | $23.2K | 7,332 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-02-15 | 2024-02-20 | 4,295 | — | $0 | 8,640 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-07 | 240 | $185.32 | $44.5K | 4,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-07 | 814 | $184.65 | $150.3K | 4,585 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-07 | 3,112 | $183.58 | $571.3K | 5,399 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 658 | $184.70 | $121.5K | 11,314 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,593 | $185.54 | $295.6K | 9,721 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 945 | $186.39 | $176.1K | 8,776 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 86 | $187.37 | $16.1K | 8,690 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 15 | $188.40 | $2.8K | 8,675 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 164 | $189.31 | $31.0K | 8,511 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 4,518 | — | $0 | 8,863 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 3,109 | — | $0 | 11,972 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 93 | $201.30 | $18.7K | 4,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 955 | $200.35 | $191.3K | 4,438 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 385 | $199.54 | $76.8K | 5,393 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 715 | $198.03 | $141.6K | 5,778 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 103 | $196.62 | $20.3K | 6,493 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-28 | 2023-04-28 | 204 | $195.46 | $39.9K | 6,596 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 779 | $194.94 | $151.9K | 7,009 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 700 | $193.93 | $135.8K | 7,788 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 151 | $193.18 | $29.2K | 8,488 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 129 | $197.08 | $25.4K | 6,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 80 | $195.65 | $15.7K | 6,929 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-04-26 | 2023-04-28 | 4,294 | — | $0 | 8,639 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-03-03 | 2023-03-07 | 2,500 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-03-03 | 2023-03-07 | 2,500 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-03-03 | 2023-03-07 | 2,500 | $96.45 | $241.1K | 22,417 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-03-03 | 2023-03-07 | 18,072 | $200.00 | $3.61M | 4,345 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-03-03 | 2023-03-07 | 2,500 | $96.45 | $241.1K | 19,917 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 11,850 | — | $0 | 11,850 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 5,724 | — | $0 | 5,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 4,603 | $189.76 | $873.5K | 17,900 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 165 | $205.87 | $34.0K | 17,735 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 172 | $209.91 | $36.1K | 17,563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 146 | $210.02 | $30.7K | 17,417 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 4,518 | — | $0 | 15,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,684 | — | $0 | 19,394 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,109 | — | $0 | 22,503 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 24,128 | — | $0 | 24,128 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |